Learn from Frank Staal what made him successful in the H2020 RecombMarch 8, 2021
Successful Recomb Review meetingMay 18, 2021
We are proud to share a great milestone of the RECOMB project: the RAG1-SCID clinical study is about to begin in the Netherlands. We are very happy that, after 15 years of research, the stem cell gene therapy developed for RAG1-SCID patients will be used in the clinic and can offer a solution for patients across Europe. Read the full press release from LUMC Newsroom.